3-Bromo-6,7,8,9-tetrahydro-5H-imidazo[1,2-a]azepine

Basic Information

View in Editor

CAS Number

701298-97-7

Molecular Formula

C8H11BrN2

Molecular Weight

215.09 g/mol

Chemical Classification

Basic Chemical Raw Materials Organic Chemicals Heterocyclic Compounds

Pharmaceutical Chemicals Pharmaceutical Intermediates Heterocyclic Intermediates

Agricultural Chemicals Pesticides Herbicides

Basic Physical Properties

SMILES

View in Editor

C1CCC2=NC=C(N2CC1)Br

InChI

InChI=1S/C8H11BrN2/c9-7-6-10-8-4-2-1-3-5-11(7)8/h6H,1-5H2

InChIKey

UWZONBZFTQTRBD-UHFFFAOYSA-N

LogP

2.3720000000000008

Topological Polar Surface Area

17.82 Å²

Hydrogen Bond Donor/Acceptor

0 / 2

Complexity

140

Synonyms & References

English

AKOS015835768
SY014015
FT-0685868
F11730
EN300-329025
A866671
DTXSID30650370
UWZONBZFTQTRBD-UHFFFAOYSA-N
CS-0145160
3-bromo-5H,6H,7H,8H,9H-imidazo[1,2-a]azepine
3-Bromo-6,7,8,9-tetrahydro-5H-imidazo[1,2-a]azepine
J-512060
BS-29282
BDB29897
701298-97-7
SCHEMBL950413
MFCD08235254
ACMC-209od1
ANW-35843
CTK5D1893
SBB054640
SureCN950413

MDL Number

MFCD08235254

Customs Code

2933990090

FAQ

What regulatory guidelines apply to 3-Bromo-6,7,8,9-tetrahydro-5H-imidazo[1,2-a]azepine (CAS: 701298-97-7)?

The compound, 3-Bromo-6,7,8,9-tetrahydro-5H-imidazo[1,2-a]azepine (CAS: 701298-97-7), is subject to various regulatory guidelines such as GHS classification, REACH regulations, and FDA/EPA requirements. It should be handled in accordance with the Globally Harmonized System of Classification and Labelling of Chemicals (GHS) for hazardous characteristics like flammability, reactivity, and toxicity. REACH regulations require registration and reporting for substances with a threshold of 1 ton per year. Additionally, the FDA and EPA may have specific regulations for its use in pharmaceuticals and environmental release, respectively.

Are there alternatives to 3-Bromo-6,7,8,9-tetrahydro-5H-imidazo[1,2-a]azepine (CAS: 701298-97-7) in synthesis?

While 3-Bromo-6,7,8,9-tetrahydro-5H-imidazo[1,2-a]azepine (CAS: 701298-97-7) is a specific compound, there are alternative reagents that can be used in synthesis. For example, bromobenzene or other imidazoles can serve as precursors. Additionally, isomers such as 2-bromo-6,7,8,9-tetrahydro-5H-imidazo[1,2-a]azepine can be considered. These alternatives can provide similar functionality but may require different synthetic pathways and may have varying regulatory requirements.

What is the market or research trend for 3-Bromo-6,7,8,9-tetrahydro-5H-imidazo[1,2-a]azepine (CAS: 701298-97-7)?

The market for 3-Bromo-6,7,8,9-tetrahydro-5H-imidazo[1,2-a]azepine (CAS: 701298-97-7) is currently growing due to its potential applications in pharmaceuticals and materials science. Research trends include its use as an intermediate in drug discovery and development. Market trends show increasing interest in its synthesis and application, but the price remains stable. However, ongoing research may lead to new applications and thus drive market demand.

How should waste containing 3-Bromo-6,7,8,9-tetrahydro-5H-imidazo[1,2-a]azepine (CAS: 701298-97-7) be handled?

Waste containing 3-Bromo-6,7,8,9-tetrahydro-5H-imidazo[1,2-a]azepine (CAS: 701298-97-7) should be handled according to the guidelines set by the Globally Harmonized System (GHS) and local environmental regulations. Waste should be collected in appropriate containers and stored in a secure, well-ventilated area. Incineration or professional disposal by a licensed waste management company is recommended. Proper precautions should be taken to prevent environmental contamination, and any spills should be cleaned up immediately using the appropriate hazardous waste cleanup procedures.